• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sex differences in mechanisms of arterial stiffness.动脉僵硬度机制的性别差异。
Br J Pharmacol. 2019 Nov;176(21):4208-4225. doi: 10.1111/bph.14624. Epub 2019 May 11.
2
Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?打破平衡:女性更容易患肥胖症和高脂肪饮食引起的高血压和血管功能障碍吗?
Br J Pharmacol. 2019 Nov;176(21):4226-4242. doi: 10.1111/bph.14783. Epub 2019 Aug 19.
3
Sex as a biological variable in the pathology and pharmacology of neurodegenerative and neurovascular diseases.性别作为神经退行性和神经血管疾病病理和药理学的生物学变量。
Br J Pharmacol. 2019 Nov;176(21):4173-4192. doi: 10.1111/bph.14675. Epub 2019 May 21.
4
The importance of sex differences in pharmacology research.药理学研究中性别差异的重要性。
Br J Pharmacol. 2019 Nov;176(21):4087-4089. doi: 10.1111/bph.14819.
5
Sex differences in schizophrenia, bipolar disorder, and post-traumatic stress disorder: Are gonadal hormones the link?精神分裂症、双相情感障碍和创伤后应激障碍中的性别差异:性腺激素是其中的联系吗?
Br J Pharmacol. 2019 Nov;176(21):4119-4135. doi: 10.1111/bph.14584. Epub 2019 Mar 14.
6
GPCRs in context: sexual dimorphism in the cardiovascular system.GPCR 在语境中:心血管系统中的性别二态性。
Br J Pharmacol. 2018 Nov;175(21):4047-4059. doi: 10.1111/bph.14160. Epub 2018 Mar 25.
7
Metabolic control and sex: A focus on inflammatory-linked mediators.代谢控制与性别:关注炎症相关介质。
Br J Pharmacol. 2019 Nov;176(21):4193-4207. doi: 10.1111/bph.14642. Epub 2019 Apr 21.
8
Arterial stiffness and its clinical implications in women.女性的动脉僵硬度及其临床意义。
Can J Cardiol. 2014 Jul;30(7):756-64. doi: 10.1016/j.cjca.2014.03.020. Epub 2014 Mar 20.
9
Sex bias in preclinical research and an exploration of how to change the status quo.临床前研究中的性别偏见及改变现状的探索
Br J Pharmacol. 2019 Nov;176(21):4107-4118. doi: 10.1111/bph.14539. Epub 2018 Dec 12.
10
New insights into arterial stiffening: does sex matter?动脉僵硬度的新见解:性别重要吗?
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1073-H1087. doi: 10.1152/ajpheart.00132.2018. Epub 2018 Jul 20.

引用本文的文献

1
Association of cardiovascular risks and carotid stiffening at ultrafast ultrasound imaging in young populations.年轻人群中超快超声成像下心血管风险与颈动脉僵硬度的关联
Eur Radiol. 2025 Sep 8. doi: 10.1007/s00330-025-11979-2.
2
Increased plasma ceramide levels are associated with arterial stiffness and vascular ageing: a cross-sectional study.血浆神经酰胺水平升高与动脉僵硬度和血管衰老相关:一项横断面研究。
Lipids Health Dis. 2025 Sep 1;24(1):272. doi: 10.1186/s12944-025-02706-3.
3
Beneficial Effects of Water-Based Exercise Alone and in Combination with Cognitive Training on Cardiovascular Fitness and Arterial Stiffness in Older Adults with Mild Cognitive Impairment: A Randomized Controlled Trial.单纯水上运动及与认知训练相结合对轻度认知障碍老年人心血管健康和动脉僵硬度的有益影响:一项随机对照试验
Life (Basel). 2025 Jul 28;15(8):1195. doi: 10.3390/life15081195.
4
The Impact of Age and Sex on Left Ventricular Function Based on Transthoracic Echocardiograms.基于经胸超声心动图评估年龄和性别对左心室功能的影响
Rev Cardiovasc Med. 2025 Jun 27;26(6):38779. doi: 10.31083/RCM38779. eCollection 2025 Jun.
5
The angiotensin II type 2 receptor attenuates aging-associated arterial stiffness in female mice.血管紧张素II 2型受体可减轻雌性小鼠与衰老相关的动脉僵硬度。
Am J Physiol Heart Circ Physiol. 2025 Aug 1;329(2):H388-H394. doi: 10.1152/ajpheart.00328.2025. Epub 2025 Jul 7.
6
Gender differences in aortic blood pressure, arterial stiffness, and cerebral blood flow in healthy adults: A STROBE-compliant cross-sectional observational study.健康成年人主动脉血压、动脉僵硬度和脑血流量的性别差异:一项符合STROBE标准的横断面观察性研究。
Medicine (Baltimore). 2025 Jun 6;104(23):e42717. doi: 10.1097/MD.0000000000042717.
7
Biological Age as a Predictor of Arterial Stiffness in Young and Early Midlife Black and White Women.生物学年龄作为年轻及中年早期黑人和白人女性动脉僵硬度的预测指标
Am J Hypertens. 2025 Aug 14;38(9):706-713. doi: 10.1093/ajh/hpaf059.
8
Safety profile of faricimab: a multi-source pharmacovigilance analysis using FAERS and JADER.法西单抗的安全性概况:一项使用FAERS和JADER的多源药物警戒分析。
BMC Pharmacol Toxicol. 2025 Apr 12;26(1):82. doi: 10.1186/s40360-025-00902-6.
9
The impact of sex on blood pressure.性别对血压的影响。
Curr Opin Nephrol Hypertens. 2025 Jul 1;34(4):322-329. doi: 10.1097/MNH.0000000000001077. Epub 2025 Apr 7.
10
Effects of Exercise on Arterial Stiffness: Mechanistic Insights into Peripheral, Central, and Systemic Vascular Health in Young Men.运动对动脉僵硬度的影响:对年轻男性外周、中枢和全身血管健康的机制性见解
Metabolites. 2025 Mar 1;15(3):166. doi: 10.3390/metabo15030166.

本文引用的文献

1
Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.肾素-血管紧张素-醛固酮系统激活在促进心血管纤维化和僵硬中的作用。
Hypertension. 2018 Sep;72(3):537-548. doi: 10.1161/HYPERTENSIONAHA.118.11065.
2
Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.性别差异在心血管病理生理学中的作用:为什么女性在射血分数保留的心力衰竭中更为常见。
Circulation. 2018 Jul 10;138(2):198-205. doi: 10.1161/CIRCULATIONAHA.118.034271.
3
Coronary artery microvascular dysfunction: Role of sex and arterial load.冠状动脉微血管功能障碍:性别和动脉负荷的作用。
Int J Cardiol. 2018 Nov 1;270:42-47. doi: 10.1016/j.ijcard.2018.06.072. Epub 2018 Jun 20.
4
Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults.慢性补充线粒体抗氧化剂(MitoQ)可改善健康老年人的血管功能。
Hypertension. 2018 Jun;71(6):1056-1063. doi: 10.1161/HYPERTENSIONAHA.117.10787. Epub 2018 Apr 16.
5
Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD in healthy middle-aged and older adults.慢性烟酰胺核糖苷补充剂耐受良好,并能提高健康中年和老年人的 NAD 水平。
Nat Commun. 2018 Mar 29;9(1):1286. doi: 10.1038/s41467-018-03421-7.
6
Smooth muscle cell and arterial aging: basic and clinical aspects.平滑肌细胞与动脉老化:基础与临床方面。
Cardiovasc Res. 2018 Mar 15;114(4):513-528. doi: 10.1093/cvr/cvy009.
7
Gender differences in acute coronary syndromes: focus on the women with ACS without an obstructing culprit lesion.急性冠状动脉综合征中的性别差异:关注无阻塞性罪犯病变的急性冠状动脉综合征女性患者。
Expert Rev Cardiovasc Ther. 2018 Apr;16(4):297-304. doi: 10.1080/14779072.2018.1443808. Epub 2018 Mar 7.
8
Smooth Muscle Cell-Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging.平滑肌细胞-盐皮质激素受体作为衰老导致心血管僵硬度的中介。
Hypertension. 2018 Apr;71(4):609-621. doi: 10.1161/HYPERTENSIONAHA.117.10437. Epub 2018 Feb 20.
9
Rho Kinase Regulates Aortic Vascular Smooth Muscle Cell Stiffness Via Actin/SRF/Myocardin in Hypertension.Rho激酶在高血压中通过肌动蛋白/血清反应因子/心肌素调节主动脉血管平滑肌细胞硬度。
Cell Physiol Biochem. 2017;44(2):701-715. doi: 10.1159/000485284. Epub 2017 Nov 23.
10
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.2018 年 IUPHAR/BPS 药理学指南:更新和扩展,以包含新的免疫药理学指南。
Nucleic Acids Res. 2018 Jan 4;46(D1):D1091-D1106. doi: 10.1093/nar/gkx1121.

动脉僵硬度机制的性别差异。

Sex differences in mechanisms of arterial stiffness.

机构信息

Molecular Cardiology Research Institute, Tufts Medical Center, Boston, Massachusetts, United States of America.

Division of Cardiology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts, United States of America.

出版信息

Br J Pharmacol. 2019 Nov;176(21):4208-4225. doi: 10.1111/bph.14624. Epub 2019 May 11.

DOI:10.1111/bph.14624
PMID:30767200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6877796/
Abstract

Arterial stiffness progressively increases with aging and is an independent predictor of cardiovascular disease (CVD) risk. Evidence supports that there are sex differences in the time course of aging-related arterial stiffness and the associated CVD risk, which increases disproportionately in postmenopausal women. The association between arterial stiffness and mortality is almost twofold higher in women versus men. The differential clinical characteristics of the development of arterial stiffness between men and women indicate the involvement of sex-specific mechanisms. This review summarizes the current literature on sex differences in vascular stiffness induced by aging, obesity, hypertension, and sex-specific risk factors as well as the impact of hormonal status, diet, and exercise on vascular stiffness in males and females. An understanding of the mechanisms driving sex differences in vascular stiffness has the potential to identify novel sex-specific therapies to lessen CVD risk, the leading cause of death in males and females. LINKED ARTICLES: This article is part of a themed section on The Importance of Sex Differences in Pharmacology Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.21/issuetoc.

摘要

动脉僵硬程度随着年龄的增长而逐渐增加,是心血管疾病(CVD)风险的独立预测因子。有证据表明,与年龄相关的动脉僵硬的时间进程和相关 CVD 风险在性别之间存在差异,绝经后女性的风险不成比例地增加。与男性相比,女性的动脉僵硬与死亡率之间的相关性高出近两倍。男性和女性之间动脉僵硬发展的临床特征差异表明存在特定于性别的机制。这篇综述总结了目前关于衰老、肥胖、高血压以及特定于性别的危险因素引起的血管僵硬的性别差异的文献,以及激素状态、饮食和运动对男性和女性血管僵硬的影响。了解导致血管僵硬性别差异的机制有可能确定新的特定于性别的治疗方法,以降低 CVD 风险,这是男性和女性的主要死亡原因。

相关文章

本文是关于药理学研究中性别差异重要性的专题部分的一部分。要查看该部分中的其他文章,请访问 http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.21/issuetoc.